Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03275025
What this trial is testing

Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Yungjin Pharm. Co., Ltd. 116
Testing effectiveness (Phase 2)Ended earlyNCT01984268
What this trial is testing

ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Dartmouth-Hitchcock Medical Center 15
Post-approval studies (Phase 4)Study completedNCT00967538
What this trial is testing

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Who this might be right for
Psoriasis
Innovaderm Research Inc. 89
Large-scale testing (Phase 3)Study completedNCT00351910
What this trial is testing

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 494
Large-scale testing (Phase 3)Study completedNCT02694523
What this trial is testing

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 684
Large-scale testing (Phase 3)Study completedNCT06383403
What this trial is testing

Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

Who this might be right for
Primary Biliary Cholangitis
Ipsen 92
Testing effectiveness (Phase 2)Ended earlyNCT02720120
What this trial is testing

Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 175
Large-scale testing (Phase 3)Study completedNCT01488071
What this trial is testing

Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 495
Post-approval studies (Phase 4)Ended earlyNCT01783015
What this trial is testing

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

Who this might be right for
Rheumatoid Arthritis
Pfizer 16
Not applicableStudy completedNCT04149587
What this trial is testing

Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 252
Post-approval studies (Phase 4)Study completedNCT00996203
What this trial is testing

Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 201
Post-approval studies (Phase 4)Ended earlyNCT00904488
What this trial is testing

Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
University of North Carolina, Chapel Hill 11
Testing effectiveness (Phase 2)Study completedNCT02153502
What this trial is testing

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Who this might be right for
Depressive Disorder, Treatment-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 206
Testing effectiveness (Phase 2)Study completedNCT03605251
What this trial is testing

Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Taiho Pharmaceutical Co., Ltd. 91
Testing effectiveness (Phase 2)Looking for participantsNCT06846320
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Who this might be right for
Generalized Anxiety Disorder (GAD)
AbbVie 315
Large-scale testing (Phase 3)Study completedNCT01157078
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive DisorderDepression
AstraZeneca 319
Testing effectiveness (Phase 2)Study completedNCT04577781
What this trial is testing

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 28
Large-scale testing (Phase 3)Active Not RecruitingNCT03675308
What this trial is testing

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

Who this might be right for
Psoriatic Arthritis
AbbVie 964
Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96
Large-scale testing (Phase 3)Ended earlyNCT04000009
What this trial is testing

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
ACADIA Pharmaceuticals Inc. 235
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation